[go: up one dir, main page]

EP1951050A4 - THERAPEUTIC COMPOSITIONS AND METHODS - Google Patents

THERAPEUTIC COMPOSITIONS AND METHODS

Info

Publication number
EP1951050A4
EP1951050A4 EP06817334A EP06817334A EP1951050A4 EP 1951050 A4 EP1951050 A4 EP 1951050A4 EP 06817334 A EP06817334 A EP 06817334A EP 06817334 A EP06817334 A EP 06817334A EP 1951050 A4 EP1951050 A4 EP 1951050A4
Authority
EP
European Patent Office
Prior art keywords
methods
therapeutic compositions
therapeutic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06817334A
Other languages
German (de)
French (fr)
Other versions
EP1951050A2 (en
Inventor
Gary D Glick
William R Roush
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan Medical School
Original Assignee
University of Michigan Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan Medical School filed Critical University of Michigan Medical School
Publication of EP1951050A2 publication Critical patent/EP1951050A2/en
Publication of EP1951050A4 publication Critical patent/EP1951050A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EP06817334A 2005-10-26 2006-10-25 THERAPEUTIC COMPOSITIONS AND METHODS Withdrawn EP1951050A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73071105P 2005-10-26 2005-10-26
PCT/US2006/041446 WO2007050587A2 (en) 2005-10-26 2006-10-25 Therapeutic compositions and methods

Publications (2)

Publication Number Publication Date
EP1951050A2 EP1951050A2 (en) 2008-08-06
EP1951050A4 true EP1951050A4 (en) 2011-04-27

Family

ID=37968472

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06817334A Withdrawn EP1951050A4 (en) 2005-10-26 2006-10-25 THERAPEUTIC COMPOSITIONS AND METHODS

Country Status (6)

Country Link
EP (1) EP1951050A4 (en)
JP (1) JP2009513644A (en)
AU (1) AU2006306347A1 (en)
CA (1) CA2627757A1 (en)
IL (1) IL191072A0 (en)
WO (1) WO2007050587A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146222A0 (en) 1999-04-30 2002-07-25 Univ Michigan Therapeutic applications of pro-apoptotic benzodiazepines
US7638624B2 (en) 2005-01-03 2009-12-29 The Regents Of The University Of Michigan Compositions and methods relating to novel benzodiazepine compounds and derivatives
EP1893218A4 (en) 2005-06-01 2011-01-12 Univ Michigan NON-SOLVATED BENZODIAZEPINE PREPARATIONS AND METHODS
EP1948191B1 (en) 2005-11-01 2013-01-16 The Regents of the University of Michigan Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
US7759338B2 (en) 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
EP2037741B1 (en) 2006-06-09 2013-11-27 The Regents Of The University Of Michigan Benzodiazepine derivatives for use in the treatment of immune, inflammatory and proliferative disorders
KR101164718B1 (en) 2007-03-09 2012-07-11 더 리젠츠 오브 더 유니버시티 오브 미시간 Compositions and methods relating to novel compounds and targets thereof
JP5416122B2 (en) 2007-09-14 2014-02-12 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン F1F0-ATPase inhibitors and related methods
WO2009061916A2 (en) 2007-11-06 2009-05-14 The Regents Of The University Of Michigan Benzodiazepinone compounds useful in the treatment of skin conditions
US8497307B2 (en) 2008-09-11 2013-07-30 The Regents Of The University Of Michigan Aryl guanidine F1F0-ATPase inhibitors and related methods
US8604023B2 (en) 2009-04-17 2013-12-10 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
WO2011035124A1 (en) 2009-09-18 2011-03-24 The Regents Of The University Of Michigan Benzodiazepinone compounds and methods of treatment using same
CA2915237C (en) 2009-11-17 2017-10-10 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
CA2780287C (en) 2009-11-17 2015-03-17 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
AR084070A1 (en) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc BROMODOMINIUM INHIBITORS AND USES OF THE SAME
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
FR2972454B1 (en) * 2011-03-08 2013-03-01 Servier Lab NOVEL DIHYDRO-OXAZOLOBENZODIAZEPINONES DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2864336B1 (en) 2012-06-06 2016-11-23 Constellation Pharmaceuticals, Inc. Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (en) 2012-06-06 2017-10-21 星宿藥物公司 Bromodomain inhibitors and uses thereof
TR201906788T4 (en) 2014-06-20 2019-05-21 Constellation Pharmaceuticals Inc Crystal forms of 2 - ((4s) -6- (4-chlorophenyl) -1-methyl-4h-benzo [c] isoxazolo [4,5-e] azepin-4-yl) acetamide.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050113460A1 (en) * 1999-04-30 2005-05-26 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962337A (en) * 1995-06-29 1999-10-05 Pharmacopeia, Inc. Combinatorial 1,4-benzodiazepin-2,5-dione library
US7144880B2 (en) * 1999-04-30 2006-12-05 Regents Of The University Of Michigan Compositions relating to novel compounds and targets thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050113460A1 (en) * 1999-04-30 2005-05-26 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
M. H. BOLLI ET AL: "Novel Benzo[1,4]diazepin-2-one Derivatives as Endothelin Receptor Antagonists", JOURNAL OF MEDICINAL CHEMISTRY, vol. 47, no. 11, 23 April 2004 (2004-04-23) - 23 April 2004 (2004-04-23), pages 2776 - 2795, XP002628675, ISSN: 0022-2623, DOI: 10.1021/jm031115r *

Also Published As

Publication number Publication date
AU2006306347A1 (en) 2007-05-03
WO2007050587A3 (en) 2007-11-29
CA2627757A1 (en) 2007-05-03
JP2009513644A (en) 2009-04-02
WO2007050587A2 (en) 2007-05-03
EP1951050A2 (en) 2008-08-06
IL191072A0 (en) 2008-12-29

Similar Documents

Publication Publication Date Title
EP1951050A4 (en) THERAPEUTIC COMPOSITIONS AND METHODS
CY2014030I1 (en) THERAPEUTIC COMPOSITIONS INCLUDING INGENOL-3-ANGELATE
EP1896050A4 (en) LKKTET AND / OR LKKTNT PEPTIDE METHODS AND COMPOSITIONS
DK2185164T3 (en) COMPOSITION AND THERAPEUTIC ANTITUMORVACCINE
EP1776148A4 (en) OPHTHALMIC DEVICES AND METHODS AND COMPOSITIONS THEREFOR
BRPI0812562A2 (en) anti-cd20 therapeutic compositions and methods
EP1991237A4 (en) CHEMOPROTECTIVE METHODS AND COMPOSITIONS
DK3424932T3 (en) Bronophthalides for therapeutic use
EP1940423A4 (en) TISSUE ENGINEERING METHOD AND COMPOSITIONS
DK1884242T3 (en) PHARMACEUTICAL COMPOSITION COMPREHENSIVE LURASIDON
EP1868459A4 (en) THERAPEUTIC SHOE
BRPI0511900A (en) pharmaceutical compositions
ATE525088T1 (en) COMBINATION THERAPY
EP1962961A4 (en) DEMIKÖRPER: DIMERIZATION-ACTIVATED THERAPEUTIC AGENT
DK2079485T3 (en) PHENYLPROPIONAMIDE COMPOUNDS AND THE USE THEREOF
IS8597A (en) Risedronate formulations and methods of use thereof
DK2001556T3 (en) Thioninium compounds and their use
DK2035369T3 (en) THERAPEUTIC
DK2069467T3 (en) Various compositions and methods of use
EP1974370A4 (en) MICROPOSITION COMPOSITION AND USE METHOD THEREFOR
DK1885716T3 (en) THIAZOLD DERIVATIVES AND USE THEREOF
DK1858481T3 (en) Ophthalmologic compositions and their use
ATE420081T1 (en) TRIFLUORMETHYLBENZAMIDE DERIVATIVES AND THERAPEUTIC USES THEREOF
DE602005008726D1 (en) USED
DE112006002272T8 (en) Catheter and catheter kit

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080506

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20110330

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110503